For example, ZFX overexpression has been observed in prostate cancer [12], gastric cancer [13–15], human gliomas [16, 17], non-small-cell lung cancer (NSCLC) [18], breast cancer [19], and so on. This evidence concerns the gene ZFX and central nervous system cancer.